Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2026 Financial Results
PR Newswire•12/10/2026•16:01 ET
0
Key Highlights
- ➤Neurocrine (NBIX) schedules Q3 2026 results release for November 2, 2026.
- ➤Q3 2026 conference call and webcast set for 1:30 p.m. Pacific Time.
- ➤Company reports FDA-approved treatments across neurological, psychiatric, endocrine and immunological disorders.
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2026 Financial Results PR Newswire
SAN DIEGO, Oct. 12, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its third quarter 2026 financial results conference call and webcast for 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on November 2, 2026.
Get started
Create a free account to read the full story.